Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: Risk-adjusted retrospective data analysis

Journal of the American College of Cardiology

Volumn 60, Issue 5, 2012, Pages 388-396

  Smith, Peter K ^a   Goodnough, Lawrence T ^b   Levy, Jerrold H ^c   Poston, Robert S ^d   Short, Mary A ^e   Weerakkody, Govinda J ^e   Lenarz, Leroy A ^e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e Lilly USA   (United States)

Author keywords

acute coronary syndrome; clopidogrel; coronary artery bypass grafting; mortality; prasugrel

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PRASUGREL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; DATA ANALYSIS; DRUG WITHDRAWAL; FEMALE; HUMAN; LOADING DRUG DOSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SURVIVAL PREDICTION; THROMBOCYTE TRANSFUSION; TREATMENT DURATION; TREATMENT OUTCOME; TUBE;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; ASPIRIN; BLOOD LOSS, SURGICAL; CAUSE OF DEATH; CHEST TUBES; COHORT STUDIES; COMBINED MODALITY THERAPY; CORONARY ARTERY BYPASS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PLATELET AGGREGATION INHIBITORS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ADJUSTMENT; THIOPHENES; TICLOPIDINE;

EID: 84864287789     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.03.030     Document Type: Article

References (24)

1. G.N. Levine, A.M. Lincoff, J.J. Ferguson 3rd Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decade Catheter Cardiovasc Interv 66 2005 149 157 (Pubitemid 41443016)
2. S.F. Aranki, S.C. Body Antiplatelet agents used for early intervention in acute coronary syndrome: myocardial salvage versus bleeding complications J Thorac Cardiovasc Surg 138 2009 807 810
3. K.A. Fox, S.R. Mehta, R. Peters Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial Circulation 110 2004 1202 1208 (Pubitemid 39202333)
4. D.L. Bhatt, D.P. Chew, A.T. Hirsch, P.A. Ringleb, W. Hacke, E.J. Topol Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery Circulation 103 2001 363 368 (Pubitemid 32105974)
5. R. Ebrahimi, C. Dyke, R. Mehran Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial J Am Coll Cardiol 53 2009 1965 1972
6. S.D. Wiviott, E. Braunwald, C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
7. C. Held, N. Asenblad, J.P. Bassand Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery results from the PLATO (Platelet Inhibition and Patient Outcomes) trial J Am Coll Cardiol 57 2011 672 684
8. G. Montalescot, J.S. Hulot, J.P. Collet Antiplatelet therapy and coronary artery bypass graft surgery: a fallow land J Am Coll Cardiol 56 2010 2003 2005
9. J.H. Kim, L.K. Newby, R.M. Clare Clopidogrel use and bleeding after coronary artery bypass graft surgery Am Heart J 156 2008 886 892
10. L. Chen, A.W. Bracey, R. Radovancevic Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting J Thorac Cardiovasc Surg 128 2004 425 431 (Pubitemid 39194700)
11. J. Barnard, R. Millner A review of topical hemostatic agents for use in cardiac surgery Ann Thorac Surg 88 2009 1377 1383
12. J.P. Bassand, R. Afzal, J. Eikelboom Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes Eur Heart J 31 2010 50 58
13. Effient (Prasugrel) Acute Coronary Syndromes Managed by Percutaneous Coronary Intervention FDA Division of Cardiovascular and Renal Drugs Advisory Committee Briefing Document, 03 February 2009 http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ CardiovascularandRenalDrugsAdvisoryCommittee/ucm129219.pdf Accessed August 8, 2011
14. S.A. Nashef, F. Roques, P. Michel, E. Gauducheau, S. Lemeshow, R. Salamon European system for cardiac operative risk evaluation (EuroSCORE) Eur J Cardiothorac Surg 16 1999 9 13 (Pubitemid 29336425)
15. R.P. Anderson First publications from the Society of Thoracic Surgeons National Database Ann Thorac Surg 57 1994 6 7 (Pubitemid 24047682)
16. S.D. Wiviott, E.M. Antman, C.M. Gibson TRITON-TIMI 38 Investigators Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38) Am Heart J 152 2006 627 635 (Pubitemid 44396884)
17. R.S. Wright, J.L. Anderson, C.D. Adams 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST- elevation myocardial infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 57 2011 e215 e367
18. F.G. Kushner, M. Hand, S.C. Smith Jr. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 54 2009 2205 2241
19. S.R. Mehta, S. Yusuf, R.J. Peters Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial (CURE) Investigators Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533 (Pubitemid 32772726)
20. R.H. Mehta, A.Y. Chen, C.V. Pollack Jr. Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST-segment elevation acute coronary syndromes Am J Cardiol 98 2006 624 627 (Pubitemid 44233458)
21. A.M. Lincoff, L.A. LeNarz, G.J. Despotis Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing Ann Thorac Surg 70 2000 516 526
22. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, K.K. Fox Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
23. L. Wallentin, R.C. Becker, A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
24. L.T. Goodnough, G.J. Despotis, P.K. Smith Transfusion requirements and outcomes in the cohort of patients undergoing isolated CABG treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis Blood 116 2010 482 483